Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Summary

This phase II trial is studying how well saracatinib works in treating patients with previously treated metastatic pancreatic cancer. Saracatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2008-10

Primary completion

2011-04

Completion

2012-10

Drugs

Indications